| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
IGF1Growth retardationAromataseGynecomastiaPuberty (BASKET)Genomic and genetic analysisReceptor (IGF1)Growth hormoneTransition patientsKidney (Minimal change nephrotic syndrome)Macrophages| 1 | 2009 | Treatment of dwarfism with recombinant human insulin-like growth factor-1. | 
| + | - | nl | Dtsch Arztebl Int 106(43):703-9 (2009) |
| 2 | 2009 | Idiopathic short stature: conundrums of definition and treatment. | 
| + | - | nl | Int J Pediatr Endocrinol 2009(-):470378 (2009) |
| 3 | 2007 | Small for gestational age: short stature and beyond. |
| + | - | nl | Endocr Rev 28(2):219-51 (2007) |
| 4 | 2000 | Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. |
| + | - | nl | Am J Manag Care 6(15 Suppl):S805-16 (2000) |
| 5 | 2006 | Growing up with idiopathic short stature: psychosocial development and hormone treatment; a critical review. |
| + | - | nl | Arch Dis Child 91(5):433-9 (2006) |
| 6 | 1995 | Investigation of developmental delay. |
| + | - | nl | Arch Dis Child 72(5):460-5 (1995) |
| 7 | 1994 | Treatment of the short, sexually immature adolescent boy. |
| + | - | nl | Arch Dis Child 71(4):285-7 (1994) |
| 8 | 1990 | Diagnosis and management of fetal growth retardation. |
| + | - | nl | Arch Dis Child 65(4 Spec No):390-4 (1990) |
| 9 | 1988 | Management of constitutional delay of growth and puberty. |
| + | - | nl | Arch Dis Child 63(9):1104-10 (1988) |
| 10 | 2008 | Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. |
| + | - | nl | J Clin Endocrinol Metab 93(11):4210-7 (2008) |
| 11 | 2008 | The role of recombinant human insulin-like growth factor-I in treating children with short stature. |
| + | - | nl | J Clin Endocrinol Metab 93(1):10-8 (2008) |
| 12 | 2007 | Defining the role of IGF-I therapy for short children. | 
| + | - | nl | J Clin Endocrinol Metab 92(3):813-4 (2007) Levitsky LL |
| 13 | 2007 | Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. |
| + | - | nl | J Clin Endocrinol Metab 92(3):804-10 (2007) |
| 14 | 1999 | Four decades of growth hormone therapy for short children: what have we achieved? |
| + | - | nl | J Clin Endocrinol Metab 84(12):4307-16 (1999) |
| 15 | 2004 | The investigation of short stature: a survey of practice in Wales and suggested practical guidelines. |
| + | - | nl | J Clin Pathol 57(2):126-30 (2004) Evans C |
| 16 | 2006 | Growth hormone therapy for short stature: is the benefit worth the burden? |
| + | - | nl | Pediatrics 118(1):343-8 (2006) |
| 17 | 2002 | Management of short stature. |
| + | - | nl | West J Med 176(3):169-72 (2002) |
| 18 | 1978 | Incidence of growth lines in psychosocial dwarfs and idiopathic hypopituitarism. |
| + | - | nl | AJR Am J Roentgenol 131(3):477-9 (1978) |
| 19 | 2010 | Recombinant human growth hormone in the treatment of patients with cystic fibrosis. |
| + | - | nl | Pediatrics 126(5):e1211-26 (2010) |
| 20 | 2008 | Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. |
| + | - | nl | Pediatrics 121(4):e975-83 (2008) |
| 21 | 2009 | Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype. |
| + | - | nl | J Clin Endocrinol Metab 94(12):4717-27 (2009) |
| 22 | 2002 | Familial isolated growth hormone deficiency: genetics and pathophysiology. |
| + | - | nl | Endocr J 49(3):265-72 (2002) |
| 23 | 2009 | American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations. |
| + | - | nl | Endocr Pract 15(6):580-6 (2009) |
| 24 | 2007 | Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy? |
| + | - | nl | Eur J Endocrinol 157 Suppl 1(-):S33-7 (2007) |
| 25 | 2007 | IGF-I therapy in growth disorders. |
| + | - | nl | Eur J Endocrinol 157 Suppl 1(-):S57-60 (2007) |
| 26 | 2007 | Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. |
| + | - | nl | Eur J Endocrinol 157(6):695-700 (2007) |
| 27 | 2011 | Growth monitoring for short stature: update of a systematic review and economic model. |
| + | - | nl | Health Technol Assess 15(11):iii-iv, 1-64 (2011) |
| 28 | 2010 | Successful treatment of dwarfism secondary to long-term steroid therapy in steroid-dependent nephrotic syndrome. |
| + | - | nl | Intern Med 49(14):1417-21 (2010) |
| 29 | 2007 | Pharmacological management of children with short stature: the role of aromatase inhibitors. |
| + | - | nl | J Pediatr (Rio J) 83(5 Suppl):S172-7 (2007) |
| 30 | 2007 | Insulin like growth factors and growth hormone deficiency. |
| + | - | nl | Indian Pediatr 44(5):349-53 (2007) |
| 31 | 2010 | CSF-1, IGF-1, and the control of postnatal growth and development. |
| + | - | nl | J Leukoc Biol 88(3):475-81 (2010) |
